Discover the complete record of transactions filed by Brennan David R, Director. Officer active across 5 companies, notably ALEXION PHARMACEUTICALS, INC.. In total, 11 reports have been published. Total volume traded: €522k. The latest transaction was filed on 1 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
David R. Brennan is a Director at INSMED Inc and ALEXION PHARMACEUTICALS, INC. In these roles, he contributes to the strategic direction of the companies and oversees their operations. His expertise in the biopharmaceutical sector is valuable in guiding Insmid and Alexion's strategic decisions.